Skip to main content
. 2022 Dec 22;11(3):825–835.e3. doi: 10.1016/j.jaip.2022.12.003

Table I.

Demographic and clinical characteristics of the post–COVID-19 study cohort

Characteristic All patients (n = 31,084) Hospitalization (n = 2863)
No hospitalization (n = 28,221)
Asthma (n = 396) No asthma (n = 2467) P value# Asthma (n =3653) No asthma (n = 24,568) P value
Demographic
 Age (y), mean (SD) 48.8 (17.8) 57.6 (16.6) 61.3 (17.1) <.001 46.4 (16.7) 47.7 (17.6) <.001
 18-29 5677 (18.3) 23 (5.8) 104 (4.2) .006 755 (20.7) 4795 (19.5) <.001
 30-39 4981 (16.0) 39 (9.8) 211 (8.6) 606 (16.6) 4125 (16.8)
 40-49 4957 (15.9) 54 (13.6) 273 (11.1) 637 (17.4) 3993 (16.3)
 50-59 6477 (20.8) 94 (23.7) 488 (19.8) 812 (22.2) 5083 (20.7)
 60-69 4912 (15.8) 89 (22.5) 549 (22.3) 525 (14.4) 3749 (15.3)
 70-80 2576 (8.3) 59 (14.9) 458 (18.6) 242 (6.6) 1817 (7.4)
 ≥80 1504 (4.8) 38 (9.6) 384 (15.6) 76 (2.1) 1006 (4.1)
 Sex, male, N (%) 12,509 (40.2) 140 (35.4) 1376 (55.8) <.001 1053 (28.8) 9940 (40.5) <.001
 Race, N (%)
 White 20,383 (65.6) 221 (55.8) 1334 (54.1) .162 2508 (68.7) 16,320 (66.4) <.001
 Black 3230 (10.4) 75 (18.9) 389 (15.8) 378 (10.3) 2388 (9.7)
 Asian 914 (2.9) 14 (3.5) 98 (4.0) 78 (2.1) 724 (2.9)
 Other/unknown 6557 (21.1) 86 (21.7) 646 (26.2) 689 (18.9) 5136 (20.9)
 Ethnicity, Hispanic 7139 (23.0) 101 (25.5) 727 (29.5) .12 864 (23.7) 5447 (22.2) .047
 Education level, N (%)
 College and above 11,030 (35.5) 141 (35.6) 619 (25.1) <.001 1326 (36.3) 8944 (36.4) <.001
 High school or equivalent 9729 (31.3) 147 (37.1) 952 (38.6) 1215 (33.3) 7415 (30.2)
 Did not complete high school 3004 (9.7) 55 (13.9) 444 (18.0) 334 (9.1) 2171 (8.8)
 Unknown 7321 (23.6) 53 (13.4) 452 (18.3) 778 (21.3) 6038 (24.6)
 Marital status, N (%)
 Single 11,499 (37.0) 120 (31.9) 556 (31.5) .013 1545 (42.3) 9041 (36.8) <.001
 Married/partnered 15,017 (48.3) 176 (46.8) 818 (46.3) 1657 (45.4) 12,050 (49.0)
 Divorced 2126 (6.8) 47 (12.5) 165 (9.3) 253 (6.9) 1578 (6.4)
 Widowed 1062 (3.4) 29 (7.7) 175 (9.9) 98 (2.7) 701 (2.9)
 Unknown 1380 (4.4) 4 (1.1) 53 (3.0) 100 (2.7) 1198 (4.9)
 Insurance type, N (%)
 Commercial 21,441 (69.3) 218 (55.2) 1168 (47.4) .035 2606 (71.4) 17,449 (71.4) <.001
 Medicare 4526 (14.6) 798 (32.4) 108 (27.3) 447 (12.2) 3173 (13.0)
 Medicaid 4511 (14.6) 66 (16.7) 469 (19.0) 577 (15.8) 3399 (13.9)
 Others 1583 (5.1) 3 (0.8) 30 (1.2) 406 (1.7) 21 (0.6)
 Smoking history, N (%)
 Never smoker 21,127 (68.0) 273 (68.9) 1491 (60.4) <.001 2554 (69.9) 16,809 (68.4) <.001
 Current smoker 1459 (4.7) 21 (5.3) 108 (4.4) 195 (5.3) 1135 (4.6)
 Former smoker 6915 (22.2) 96 (24.2) 729 (29.6) 882 (24.1) 5208 (21.2)
 Unknown 1583 (5.1) 6 (1.5) 139 (5.6) 22 (0.6) 1416 (5.8)
 Body mass index, mean (SD) 29.4 (6.6) 32.6 (7.8) 29.5 (6.6) <.001 31.1 (7.5) 29.1 (6.4) <.001
 ≤24.9 7541 (24.3) 59 (14.9) 589 (23.9) <.001 746 (20.4) 6147 (25.0)
 25-29.9 9654 (31.1) 108 (27.3) 863 (35.0) 1061 (29.0) 7620 (31.0)
 ≥30 11,511 (37.0) 229 (57.8) 1015 (41.1) 1793 (49.1) 8474 (34.5)
 Unknown 2378 (7.7) n/a n/a 53 (1.5) 2327 (9.5)
 Comorbidities§, N (%)
 Diabetes mellitus 4065 (13.1) 127 (32.1) 737 (29.9) .409 547 (15.0) 2654 (10.8) <.001
 Hypertension 9452 (30.4) 246 (62.1) 1326 (53.7) .002 1176 (32.2) 6704 (27.3) <.001
 Chronic kidney disease 1931 (6.2) 65 (16.4) 484 (19.6) .151 172 (4.7) 1210 (4.9) .6
 Chronic liver disease 2196 (7.1) 60 (15.2) 278 (11.3) .032 348 (9.5) 1510 (6.1) <.001
 Cardiovascular disease 4414 (14.2) 156 (39.4) 787 (31.9) .004 560 (15.3) 2911 (11.8) <.001
 Anxiety 5475 (17.6) 114 (28.8) 422 (17.1) <.001 1007 (27.6) 3932 (16.0) <.001
 Depression 4865 (15.7) 132 (33.3) 503 (20.4) <.001 906 (24.8) 3324 (13.5) <.001
 Charlson comorbidity index 0.7 (1.7) 1.5 (2.5) 2.0 (2.6) <.001 1.2 (1.9) 0.5 (1.5) <.001
 Baseline respiratory symptoms
 Shortness of breath 4607 (14.8) 158 (39.9) 422 (17.1) <.001 1105 (30.2) 2922 (11.9) <.001
 Cough 4996 (16.1) 152 (38.4) 389 (15.8) <.001 1119 (30.6) 3336 (13.6) <.001
 Bronchospasm 624 (2.0) 52 (13.1) 15 (0.6) <.001 452 (12.4) 105 (0.4) <.001
 Wheezing 2339 (7.5) 154 (38.9) 151 (6.1) <.001 1192 (32.6) 842 (3.4) <.001
 Abnormal breathing 1408 (4.5) 66 (16.7) 174 (7.1) <.001 296 (8.1) 872 (3.5) <.001
 Respiratory syndrome 517 (1.7) 11 (2.8) 28 (1.1) .017 142 (3.9) 336 (1.4) <.001
 Sputum color change 294 (0.9) 21 (5.3) 27 (1.1) <.001 82 (2.2) 164 (0.7) <.001
 Stridor 155 (0.5) 3 (0.8) 19 (0.8) 1.0 38 (1.0) 95 (0.4) <.001

Hospitalization status determined by treatment site during the acute COVID-19 period (days: 0-27).

n/a, Not applicable; SD, standard deviation.

Age at cohort entry (COVID-19–positive test result).

Legal sex. Gender identity not available.

Self-reported.

§

Defined as ≥1 ICD code in the 12 months before the positive COVID-19 test result.